Quick Heal Technologies closed its first day on the stock exchange in February 2016 worth about ₹1,778 crore. Ten years on, in September 2026, the market values the same company at roughly ₹827 crore ($86 million) — less than half — even as the enterprise cybersecurity business it bet the next decade on, Seqrite, is now growing faster than the antivirus product that built the company in the first place.
That is the puzzle at the centre of Quick Heal’s story: a business that identified its own mortality early, built a credible second act, and is still watching its market value shrink while that second act works. Understanding why means going back to a one-room calculator repair shop in Pune in 1991, long before “cybersecurity” was a word anyone in India used.
Quick facts
| Company | Quick Heal Technologies Limited |
| Founded | 1993, Pune, as CAT Computer Services; renamed Quick Heal Technologies in 2007 |
| Founders | Kailash Katkar (Chairman and Managing Director) and Sanjay Katkar (Joint Managing Director and CTO) |
| Businesses | Quick Heal (consumer antivirus and security software) and Seqrite (enterprise cybersecurity) |
| FY25 revenue | ₹280 crore, consolidated (year ended March 2025) |
| FY25 net profit | ₹5 crore, consolidated (year ended March 2025) |
| Listed | 18 February 2016, BSE and NSE (ticker: QUICKHEAL) |
| Market value | About ₹827 crore as of 18 September 2026 |
| Key people | Kailash Katkar and Sanjay Katkar remain executive promoters; early backer Sequoia Capital fully exited in September 2023 |
What they do
Quick Heal Technologies sells software that stops other software from doing damage. It operates under two brands aimed at two very different customers. The original Quick Heal brand sells antivirus and internet-security subscriptions to Indian households and small businesses through a network of retail dealers, largely on annual licences bought with a computer or a phone. The newer Seqrite brand sells endpoint security, unified threat management, mobile device management and, more recently, data-privacy and anti-fraud tools to mid-sized and large Indian enterprises, government bodies and international customers, competing for multi-year contracts rather than single-user renewals. The company has said it operates in more than 70 countries, though India remains its core market for both brands.
The origin
Kailash Katkar left school without finishing it and, in 1985, started working at a calculator and radio repair shop in Pune. By 1991 he had saved enough to open his own calculator repair business with about ₹15,000 in a 100-square-foot space. Two years later, in 1993, seeing computers replace calculators in small offices, he set up CAT Computer Services to maintain and repair them — and won an early annual maintenance contract with New India Assurance that gave the fledgling business credibility.
The founding insight for the product that would define the company came from his younger brother. Sanjay Katkar, then studying computer science, wrote an antivirus program for DOS-based computers in 1994 after the brothers kept encountering machines crippled by viruses during repair calls. Kailash priced the resulting product at ₹700 a copy — well under what imported antivirus software cost at the time — and it sold. What had been a repair shop was becoming a software company almost by accident, because the problem it was solving for its own repair customers turned out to be a problem every computer owner in the country had.
The struggle years
The early growth was real but fragile. By 1996-97 turnover had reached only about ₹12 lakh, and in 1999, during the dot-com downturn, Kailash Katkar has said he came close to shutting the company down altogether — a specific, dated near-failure rather than a vague founder anecdote. The business survived on the strength of its retail antivirus sales through the 2000s, moving to a larger office in 2002 and opening its first branch outside Pune, in Nashik, in 2003, before formally taking the Quick Heal Technologies name in 2007.
A second, slower-moving crisis has played out in public markets since listing. Days after its February 2016 debut, the stock fell more than 30% below its issue price as investors questioned growth prospects for a company almost entirely dependent on consumer antivirus licences. That scepticism has been borne out in the underlying numbers: consolidated revenue fell from ₹342 crore in FY22 to ₹278 crore in FY23, and net profit collapsed by 79.2% year-on-year in FY25, with net margin dropping from 8.3% in FY24 to 1.8% in FY25, according to an Equitymaster analysis of the company’s FY25 annual report. Operating cash flow turned negative, at about -₹22 crore for the year. A company that once looked like it might be a single-product story stuck in a shrinking category has, more than once, had to prove it was something else.
The turning point
The pivot that mattered most was not a single announcement but a sequence: Quick Heal launched its enterprise security brand, Seqrite, in February 2015, and then acquired IT security firm Junco Technologies in 2016 to build out Seqrite’s consulting and services capability, with the acquired entity becoming a subsidiary effective 13 November 2016. At the time, Quick Heal’s revenue was overwhelmingly a consumer antivirus story — a category any analyst could see would eventually be squeezed by free, operating-system-bundled protection such as Microsoft Defender.
The numbers on each side of that bet are now visible. In the July-September 2025 quarter (Q2 FY26), Seqrite’s enterprise segment brought in ₹36.9 crore, up 30% year-on-year, versus ₹59.5 crore from the consumer segment, up a slower 8.3%, putting enterprise at roughly 44% of that quarter’s ₹83.5 crore total revenue. By the following quarter, October-December 2025 (Q3 FY26), the divergence had widened further: enterprise revenue grew 37.1% year-on-year while consumer revenue fell 21.2%, according to reporting on the company’s results by Digital Terminal and ScanX. A business built entirely on one shrinking product a decade ago now has a second, growing one doing an increasing share of the work.
The money behind it
Quick Heal’s growth was mostly self-funded in its first two decades, built out of repair-shop and antivirus-licence cash flow rather than venture rounds. The one institutional investor of note was Sequoia Capital, which put in ₹60 crore in 2010 for a stake reported at just over 10%, funding the international expansion that followed — offices in Japan and the United States in 2012, and in Africa and the United Arab Emirates in 2013. Sequoia sold down part of its holding through Quick Heal’s own IPO in February 2016, reducing its stake to about 4.1%, and exited entirely in September 2023 by selling its remaining roughly 3.4% stake — 1.78 million shares — worth about ₹42.86 crore in the open market, according to Business Standard’s reporting at the time.
The IPO itself raised ₹451.25 crore in February 2016: a ₹250 crore fresh issue plus an offer for sale worth ₹201.25 crore, priced at ₹321 a share. Based on the roughly 7.0 crore shares outstanding after listing, that implied a market capitalisation near ₹2,248 crore at the issue price, though the stock’s weak debut meant it actually closed its first trading day worth about ₹1,778 crore, per Chittorgarh’s IPO data. Kailash and Sanjay Katkar have remained the company’s controlling promoters and executive leadership throughout; there has been no subsequent large external funding round, and no plan to raise fresh primary capital has been reported since the 2016 listing.
How it makes money
The consumer side of the business runs on annual subscription licences for Quick Heal antivirus and internet security, sold mostly through a dealer and distributor network spread across metros and smaller towns rather than direct online sales, which keeps customer acquisition costs low but ties revenue to a channel Quick Heal does not fully control. The enterprise side, Seqrite, sells endpoint protection, network security appliances, mobile device management and newer offerings such as a Data Privacy Management Platform and the AntiFraud.AI product launched in October 2024, typically on multi-year contracts with larger deal sizes and, based on the company’s own reporting, materially better growth than the consumer book.
The part outsiders tend to get wrong is treating Quick Heal as simply “an antivirus company.” Its costs are dominated by research and development, channel incentives and the sales and marketing needed to defend a shrinking consumer franchise while building an unproven enterprise one at the same time — which is precisely why margins have been so unstable even as revenue has held roughly steady. Operating margin fell from 6.0% in FY24 to 2.4% in FY25, per the Equitymaster analysis cited above, largely because the company was still paying to run both businesses at once without the consumer side generating enough surplus to cushion the transition.
The numbers
Consolidated revenue and net profit for the four most recent full financial years, compiled from company results filed with the exchanges (via Screener.in) and cross-checked against Equitymaster’s independent annual-report analyses:
| Financial year (ended March) | Revenue (₹ crore) | Net profit (₹ crore) |
|---|---|---|
| FY22 | 342 | 83 |
| FY23 | 278 | 6 |
| FY24 | 292 | 24 |
| FY25 | 280 | 5 |
The pattern is not a smooth decline; it is a business bouncing along a low ceiling. Revenue has moved in a narrow ₹278-342 crore band for four years, while profit has swung far more violently, from ₹83 crore in FY22 to as little as ₹5-6 crore in two of the following three years. FY26 has shown early signs of a turn: Q2 FY26 (July-September 2025) profit after tax was ₹7.9 crore, nearly double the ₹4.2 crore recorded in the same quarter a year earlier, on EBITDA that rose 200.7% year-on-year to ₹9.2 crore, an 11.1% margin, according to results coverage by AlphaStreet.
Where the money comes from
By value, Quick Heal’s revenue still splits close to evenly between its two brands, and the split is moving in one direction. For Q2 FY26, results coverage reported consumer segment revenue of ₹59.5 crore and enterprise segment revenue of ₹36.9 crore against total revenue of ₹83.5 crore — the segment figures add up to more than the reported total, a gap the coverage reviewed for this piece did not reconcile, most likely because segment revenue is reported gross of inter-segment items while the headline figure is net. Treat the exact split with that caveat; the direction is not in doubt. Enterprise revenue has grown between 30% and 37% year-on-year in the two most recently reported quarters (Q2 and Q3 FY26), while consumer revenue growth has been low single digits at best and outright negative, down 21.2% year-on-year, in Q3 FY26.
The surprise is not that Seqrite is growing — that was the plan from 2015 onward — but how quickly it has become large enough to move the consolidated numbers at all, in a company whose brand recognition with the Indian public is still almost entirely built on the consumer product. Quick Heal’s own annual report states that Seqrite holds more than 30% market share in India’s enterprise cybersecurity solutions space; that is a company-stated figure rather than one verified by an independent market-share study, and readers should treat it accordingly.
The risks
The first risk is structural, not competitive: paid consumer antivirus is a shrinking category everywhere, as operating systems bundle increasingly capable free protection. Quick Heal’s own consumer segment revenue fell 21.2% year-on-year in Q3 FY26, and broader industry data compiled by Security.org shows Microsoft Defender alone held a leading, if slightly declining, share of the consumer antivirus category globally in 2025. A shrinking core product means the company must keep growing its newer business simply to stand still.
The second risk is that the newer business faces a harder set of competitors than the old one did. Seqrite is not just up against other Indian vendors; enterprise cybersecurity globally is increasingly dominated by far larger, better-capitalised players such as CrowdStrike, Palo Alto Networks and Microsoft Defender for Business, any of which can outspend Quick Heal many times over on research and go-to-market. Growing fast off a small base is easier than continuing to grow fast once that base gets noticed by bigger rivals.
The third risk sits in the numbers themselves: profitability has been volatile enough to erase most of a year’s earnings in the space of one bad quarter. FY25 net profit fell 79.2% year-on-year and operating cash flow turned negative, according to the Equitymaster analysis of the FY25 annual report, while finance costs rose 69.2% over the same period. A company running two businesses of similar size on thin margins has little room to absorb a slow quarter in either one.
The takeaway
Quick Heal’s most useful lesson is not about antivirus software at all. It is about what it actually costs to replace a product before it dies rather than after. The company saw the consumer antivirus ceiling coming years in advance and built Seqrite to answer it, and by the numbers, that bet is now paying off in growth terms. But building the replacement while still running the original meant carrying two cost bases against one shrinking and one still-small revenue stream at the same time, which is exactly why profit, not revenue, was the number that nearly disappeared. Seeing the wave coming is necessary. It is not the same as being able to afford the years it takes to ride it out.
Frequently asked questions
What does Quick Heal Technologies actually sell?
Two things: consumer antivirus and internet-security software under the Quick Heal brand, sold mainly through retail dealers in India, and enterprise cybersecurity products — endpoint protection, network security and data-privacy tools — under the Seqrite brand, sold to businesses and government bodies on contract.
Who founded Quick Heal and when?
Brothers Kailash and Sanjay Katkar founded the business in Pune. Kailash started a computer maintenance operation called CAT Computer Services in 1993; Sanjay wrote the DOS antivirus program that became Quick Heal in 1994. The company took the Quick Heal Technologies name in 2007.
Is Quick Heal Technologies profitable?
Yes, but thinly and unevenly. Consolidated net profit was ₹5 crore on ₹280 crore of revenue in FY25 (year ended March 2025), down 79.2% year-on-year, though FY26 has shown early signs of recovery, with Q2 FY26 profit after tax of ₹7.9 crore.
What is Seqrite and why does it matter to the company?
Seqrite is Quick Heal’s enterprise cybersecurity brand, launched in February 2015. It is growing faster than the older consumer antivirus business — enterprise revenue rose 30-37% year-on-year in the two most recent reported quarters (Q2 and Q3 FY26) — and now makes up a substantial share of total revenue.
What is Quick Heal Technologies worth today, and is Sequoia Capital still an investor?
Its market capitalisation was about ₹827 crore as of 18 September 2026, per Business Standard and Stockanalysis.com. Sequoia Capital, an early institutional backer that invested ₹60 crore in 2010, fully exited its remaining stake in September 2023. This is factual information, not investment advice.
Sources
Figures are as of September 2026. Currency converted at $1 ≈ ₹96.0 as of 18 September 2026 (Trading Economics).
- The Better India, “Kailash Katkar Built Quick Heal, India’s Most Trusted IT Security Firm” (company founding history, 1985-2013)
- Wikipedia, “Quick Heal” entry (corporate history, rebranding, Seqrite/Junco Technologies acquisition, September 2026 revision)
- Business Standard, “Quick Heal extends losses after weak debut” and “Quick Heal slumps further; down over 30% against IPO price” (February 2016)
- Business Standard, “IPO REVIEW: Quick Heal Technologies” (February 2016)
- Chittorgarh, “Quick Heal Technologies IPO Date, Price, GMP, Details” (IPO shares outstanding, listing-day market capitalisation)
- Inc42, “Sequoia Backed Quick Heal Files For An IPO” (Sequoia Capital pre-IPO stake)
- Business Standard, “Quick Heal soars 36% in 6 days after Sequoia Capital offloads entire stake” (October 2023)
- Screener.in, Quick Heal Technologies consolidated financial data (FY21-FY25 revenue and net profit)
- Equitymaster, “Quick Heal Technologies 2024-25 Annual Report Analysis” and “2022-23 Annual Report Analysis”
- Business Standard, “Quick Heal Technologies Ltd Share Price” page (market capitalisation and share price, 18 September 2026)
- Stockanalysis.com, “Quick Heal Technologies (NSE:QUICKHEAL) Market Cap & Net Worth” (market capitalisation, 18 September 2026)
- AlphaStreet, “Quick Heal Q2 FY26 Earnings Results” (October 2025)
- ScanX / Digital Terminal, coverage of Quick Heal Technologies Q2 and Q3 FY26 results (consumer and enterprise segment revenue)
- Security.org, “2026 Antivirus Trends, Statistics, and Market Report” (Microsoft Defender consumer market share)
- Medianama, “Quick Heal acquires Junco Technologies, launches cyber security consulting” (June 2016)
Found an error? Write to us and we’ll correct it in the open, dated, on the piece.

